130 related articles for article (PubMed ID: 38682958)
21. Analytical interference of HBOC-201 (Hemopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms.
Korte EA; Pozzi N; Wardrip N; Ayyoubi MT; Jortani SA
Clin Chim Acta; 2018 Jul; 482():33-39. PubMed ID: 29580857
[TBL] [Abstract][Full Text] [Related]
22. Anti-Ge2: further evidence for lack of clinical significance.
Karunasiri D; Lowder F; Ostrzega N; Goldfinger D
Immunohematology; 2014; 30(4):156-7. PubMed ID: 25831262
[TBL] [Abstract][Full Text] [Related]
23. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype.
Brumit MC; Carnahan GE; Stubbs JR; Storry JR; Reid ME
Immunohematology; 2002; 18(2):40-2. PubMed ID: 15373563
[TBL] [Abstract][Full Text] [Related]
24. Bovine hemoglobin: a nontraditional approach to the management of acute anemia in a Jehovah's Witness patient with autoimmune hemolytic anemia.
Jordan SD; Alexander E
J Pharm Pract; 2013 Jun; 26(3):257-60. PubMed ID: 22869910
[TBL] [Abstract][Full Text] [Related]
25. Hemoglobin-Based Oxygen Carrier Rescues Double-Transplant Patient From Life-Threatening Anemia.
Gomez MF; Aljure O; Ciancio G; Lynn M
Am J Transplant; 2017 Jul; 17(7):1941-1944. PubMed ID: 28188676
[TBL] [Abstract][Full Text] [Related]
26. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
[TBL] [Abstract][Full Text] [Related]
27. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
28. Anti-Rh17 (anti-Hr0): a rare diagnostic and management problem.
Salamat N; Bhatti FA; Hussain A; Ziaullah
J Pak Med Assoc; 2004 Apr; 54(4):215-8. PubMed ID: 15242002
[No Abstract] [Full Text] [Related]
29. Acute Hemolytic Transfusion Reaction Due to the "Anti-E" Rhesus Antibody in a Patient with Crohn's Disease.
Ahn A; Hwang SH
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532084
[TBL] [Abstract][Full Text] [Related]
30. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
31. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
[TBL] [Abstract][Full Text] [Related]
32. Resuscitation of an exsanguinated obstetrics patient with HBOC-201: A case report.
Barrett CD; Theodore S; Dechert T; Burke P; Khoury R; Cap AP; Scantling D
Transfusion; 2022 Aug; 62 Suppl 1():S218-S223. PubMed ID: 35748693
[TBL] [Abstract][Full Text] [Related]
33. [Alloimmunization to a high frequency Rh antigen].
Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
[TBL] [Abstract][Full Text] [Related]
34. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial.
Levy JH; Goodnough LT; Greilich PE; Parr GV; Stewart RW; Gratz I; Wahr J; Williams J; Comunale ME; Doblar D; Silvay G; Cohen M; Jahr JS; Vlahakes GJ
J Thorac Cardiovasc Surg; 2002 Jul; 124(1):35-42. PubMed ID: 12091806
[TBL] [Abstract][Full Text] [Related]
35. Maternal red blood cell alloimmunisation Working Party, literature review. RH blood group system: Rare specificities.
Floch A
Transfus Clin Biol; 2021 Aug; 28(3):314-320. PubMed ID: 33895380
[TBL] [Abstract][Full Text] [Related]
36. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury.
Raval JS; Madden KM; Neal MD; Moore SA
Transfusion; 2021 Jul; 61 Suppl 1():S144-S149. PubMed ID: 34269429
[TBL] [Abstract][Full Text] [Related]
37. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
[TBL] [Abstract][Full Text] [Related]
38. Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
Cash KL; Brown T; Sausais L; Uehlinger J; Reed LJ
Transfusion; 1999 Aug; 39(8):834-7. PubMed ID: 10504118
[TBL] [Abstract][Full Text] [Related]
39. First report of the rare RhCE-depleted D--phenotype in sixteen people of Iranian origin.
Shahverdi E; Moghaddam M; Abolghasemi H
Vox Sang; 2019 Apr; 114(3):256-261. PubMed ID: 30784072
[TBL] [Abstract][Full Text] [Related]
40. Variant RH alleles and Rh immunisation in patients with sickle cell disease.
Sippert E; Fujita CR; Machado D; Guelsin G; Gaspardi AC; Pellegrino J; Gilli S; Saad SS; Castilho L
Blood Transfus; 2015 Jan; 13(1):72-7. PubMed ID: 24960646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
